The Gravity-Assisted Paedi-Gav Valve in the Treatment of Pediatric Hydrocephalus
Authors:
- Torstein R. MelingTMTorstein R. Meling
- Arild EggeAEArild Egge
- Bernt Due-TønnessenBDBernt Due-Tønnessen
- 1 February 2005
- journal article
- clinical trial
- Published by S. Karger AG in Pediatric Neurosurgery
- Vol. 41 (1) , 8-14
Abstract
Objective: A single-center, prospective, nonrandomized pilot study was performed to assess the Paedi-Gav gravity-assisted valve for the treatment of pediatric patients with hydrocephalus. Methods: Participants were pediatric patients (age <16 years) who were candidates for a hydrocephalus shunt system that required a valve insertion at the time of enrollment. The primary outcome event was shunt malfunction; subclassified into shunt obstruction, shunt overdrainage, loculated ventricles, or infection. The shunt obstructions were further subclassified according to site. A total of 32 patients were enrolled onto the study, with 2 undergoing first shunt insertion after failed ventriculostomy and 30 undergoing shunt revisions. On average, the patients had had 3.3 shunt procedures prior to insertion of a Paedi-Gav valve. Results: During a follow-up interval of minimum 52 weeks and a median of 24 months after the first implantation on-study, shunt revisions were required in 17 (53.1%) of the 32 patients. The 12-month shunt-survival rate without revision of any component was 53%, with a median shunt-survival time of 388 days. The most common reasons for shunt revision were shunt obstructions (12/17) and overdrainage (3/17). Shunt obstructions were caused by valve-related failures (9/12) and distal obstructions (3/12). Conclusion: Although the small number of patients enrolled in this study warrants cautious conclusions, the overall results are comparable to those reported for primary shunt insertions with conventional valves in pediatric patients with hydrocephalus. Although this study provides a rationale for examining the Paedi-Gav gravity-assisted shunt valve in a larger prospective randomized controlled trial, the shunt failure pattern, with a rather high frequency of valve-related failures, may indicate potential for further improvements in the valve design and/or manufacturing.Keywords
This publication has 16 references indexed in Scilit:
- Treatment of hydrocephalus determined by the European Orbis Sigma Valve II survey: a multicenter prospective 5-year shunt survival study in children and adults in whom a flow-regulating shunt was usedJournal of Neurosurgery, 2003
- Five Years Experience with Gravitational Shunts in Chronic Hydrocephalus of AdultsActa Neurochirurgica, 2002
- Risk factors for repeated cerebrospinal shunt failures in pediatric patients with hydrocephalusJournal of Neurosurgery, 2000
- A Search for Determinants of Cerebrospinal Fluid Shunt Survival: Retrospective Analysis of a 14-Year Institutional ExperiencePediatric Neurosurgery, 1993
- Shunt Obstruction: A Preventable Complication?Pediatric Neurosurgery, 1993
- Hydrocephalus: Overdrainage by ventricular shunts. A review and recommendationsSurgical Neurology, 1991
- Mechanical Complications in ShuntsPediatric Neurosurgery, 1991
- A new approach in the treatment of hydrocephalusJournal of Neurosurgery, 1987
- Overdrainage phenomena in shunt treated hydrocephalusActa Neurochirurgica, 1978
- Anti-siphon and reversible occlusion valves for shunting in hydrocephalus and preventing post-shunt subdural hematomasJournal of Neurosurgery, 1973